OptimizeRx Corporation

OPRX - Financial Snapshot

Metrics for OPRX

Price $5.99
Shares Outstanding 18.76M
All-Time Low $0.60
52-Week Low $3.99

Balance Statement Metrics

Net Cash / Share $0
cashValuePerShare = (Cash + Short Term Investments - Total Liabilities) / Shares Outstanding
⇒ cashValuePerShare = ((19,519,000 - 48,058,000) / 18,762,203) = -1.5211
Net Current Assets / Share $0.44
netCurrentAssetsPerShare = (Current Assets - Total Liabilities) / Shares Outstanding
⇒ netCurrentAssetsPerShare = ((56,320,000 - 48,058,000) / 18,762,203) = 0.4404
Net Tangible Assets / Share $0.48
netTangibleAssetsPerShare = (Total Assets - Intangibles - Total Liabilities) / Shares Outstanding
⇒ netTangibleAssetsPerShare = ((170,321,000 - 113,306,000 - 48,058,000) / 18,762,203) = 0.48
Shares Outstanding Ave Change (Annual) 1.09%
Shares Δ YoY 1.62%
Avg CA Burn (Annual %) -19.97% (as of 2-20-2026)
Avg CA Burn (Quarterly %) 4.90% (as of 2-20-2026)

Earning Metrics

Max Earning Power / Share $1.67
maxEarningPowerPerShare = (EBITDA / EP_MULTIPLIER) / Shares Outstanding
⇒ maxEarningPowerPerShare = ((3,284,000 / 0.105) / 18,762,203) = 1.667
Adjusted Earning Power $0.4
adjustedEarningPower = (Net Income / EP_MULTIPLIER) / Shares Outstanding
⇒ adjustedEarningPower = ((779,000 / 0.105) / 18,762,203) = 0.3954
Non-Cash Charges to Market Cap 0.96%
nonCashChargeToMKTCAP = Non-Cash Charges / Market Capitalization
Avg EBITDA (5Y) 611.9K (as of 2-20-2026)
Avg EBITDA (5Q) 2.5M (as of 2-20-2026)
Avg Net Income (5Y) -12.2M (as of 2-20-2026)
Avg Net Income (5Q) -1.8M (as of 2-20-2026)
Data as of: Price 03-20-26 16:00 ET, Balance Sheet 2025-09-30, Income Statement 2025-09-30, Cash Flow 2025-09-30

Indicators

Dividend indicators Value Date
Current Dividend Streak No 2-20-2026
Consecutive Years Paid No 2-20-2026
Pays Dividend No 2-20-2026
Last Dividend Date 5-13-18
Income indicators Value Date
EBITDA Positive Yes 2-20-2026
Net Income Positive Yes 2-20-2026
Current Dividend Streak No 2-20-2026

Metric History Explorer

Pick a metric to view its history table and chart.

Tangible Book Value Per Share History

Formula: Tangible Book Value / shares from balance statements. Includes 5 quarterly + 4 annual.

Chart plots one TBV / Share point per report date (duplicate same-date annual/quarterly rows are merged).

Report Date Period TBV / Share Tangible Book Value Shares Used
2025-09-30 Quarterly $0.48 9M ($8,957,000) 18.6M (18,592,442)
2025-06-30 Quarterly $0.27 4.9M ($4,923,000) 18.6M (18,555,991)
2025-03-31 Quarterly $0.05 895K ($895,000) 18.5M (18,492,789)
2024-12-31 Quarterly $0.03 613K ($613,000) 18.5M (18,453,300)
2024-12-31 Annual $0.03 613K ($613,000) 18.5M (18,453,300)
2024-09-30 Quarterly $-0.16 -2.9M ($-2,883,000) 18.3M (18,328,035)
2023-12-31 Annual $-0.07 -1.2M ($-1,200,000) 18.2M (18,158,282)
2022-12-31 Annual $5.30 90.4M ($90,414,046) 17.1M (17,074,173)
2021-12-31 Annual $5.93 106M ($105,993,032) 17.9M (17,860,975)

Dividend Payments

Historical cash dividends per share from Yahoo ex-dividend dates.

Date Dividend / Share
No dividend payment history available yet

Shares Outstanding Changes

Date Shares Outstanding Delta
2026-03-19 18,762,203 +2,614
2026-03-17 18,759,589 +118,937

Short Interest Changes

Latest short-interest change: 1,398,242 shares (7.95% of float) | Days to cover: 3.18

Date Short Interest Delta Δ %
2026-03-12 1,398,242 shares -274,804 -16.43%
2026-02-27 1,673,046 shares +757 +0.05%
2026-02-11 1,672,289 shares +41,330 +2.53%

Interesting Volume Days

Volume/ratio use shares outstanding as of the event date (frozen).

Date Volume Shares Outstanding Volume / Shares Price
No interesting volume events

OptimizeRx Corporation operates as a digital healthcare technology company. The company offers Dynamic Audience Activation Platform, which generates dynamic audiences with predictive analytics through machine learning methods; Micro-Neighborhood Targeting, which creates consumer audiences using a privacy-first process; Profiler, which provides insights into its customers' target consumers; banner messages, including brand messaging, therapeutic support messaging, affordability messaging, HUB awareness, limited distribution drug information, and patient support program messaging through healthcare professionals; and media execution solutions, which deliver messages through consumer omnichannel network, including through programmatic display, programmatic connected television/over-the-top, programmatic social media, addressable television, digital out-of-home, programmatic audio, and email/direct mail. It also offers pharmacy alerts, which flag pharmacies that have prescription medications in stock; and financial messaging solutions, which provide prescribers visibility to branded copay offers for patients directly within electronic health record systems and ePrescribing platforms. The company was founded in 2006 and is based in Waltham, Massachusetts.